Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status

Vaccination against herpes zoster in developed countries

(2013) Mélanie Drolet et al.   Human Vaccines & Immunotherapeutics

Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study

(2013) Sinéad M. Langan et al.   PLOS MEDICINE

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

(2012) K. E. Schmader et al.   CLINICAL INFECTIOUS DISEASES

Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system

(2012) J. L. St Sauver et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Comparing Shingles Incidence and Complication Rates From Medical Record Review and Administrative Database Estimates: How Close Are They?

(2011) B. P. Yawn et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease

(2011) Hung Fu Tseng   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Health Care Utilization and Cost Burden of Herpes Zoster in a Community Population

(2009) Barbara P. Yawn et al.   MAYO CLINIC PROCEEDINGS

Diagnosis and Assessment of Pain Associated With Herpes Zoster and Postherpetic Neuralgia

(2008) Robert H. Dworkin et al.   JOURNAL OF PAIN

Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors

(2008) Peng-jun Lu et al.   VACCINE

Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older

(2008) Alicia N. Stein et al.   VACCINE